Cargando…
Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
BACKGROUND: Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be helpful in the diagnosis and monitoring the response to treatment. CASE PRESENTATI...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909206/ https://www.ncbi.nlm.nih.gov/pubmed/20587067 http://dx.doi.org/10.1186/1471-2407-10-338 |
_version_ | 1782184286836752384 |
---|---|
author | Rakha, Serena Bayliss, Clare Sanderson, Frances Smith, Richard Seckl, Michael Savage, Philip |
author_facet | Rakha, Serena Bayliss, Clare Sanderson, Frances Smith, Richard Seckl, Michael Savage, Philip |
author_sort | Rakha, Serena |
collection | PubMed |
description | BACKGROUND: Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be helpful in the diagnosis and monitoring the response to treatment. CASE PRESENTATION: In this case of a 36 year old woman, the elevated hCG level at presentation was helpful in making a clinical diagnosis of OGCT in a patient too unwell to permit a tissue diagnosis. Cisplatin based combination chemotherapy produced an initial normalisation of the hCG level, but later in treatment the patient developed new cerebral lesions and a rising serum hCG suggestive of disease progression. Further investigations suggested that the CNS lesions were cerebral TB and that the low levels of hCG elevations was likely to be pituitary in origin. Chemotherapy treatment was continued along with anti-tuberculous therapy and 24 months after successful completion of therapy the patient remains disease free. CONCLUSIONS: In the treatment of cancer patients it may be helpful to consider the potential non-malignant causes of new CNS lesions and that low hCG elevations may result from physiology rather than pathology in selected cases. |
format | Text |
id | pubmed-2909206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29092062010-07-24 Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour Rakha, Serena Bayliss, Clare Sanderson, Frances Smith, Richard Seckl, Michael Savage, Philip BMC Cancer Case Report BACKGROUND: Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be helpful in the diagnosis and monitoring the response to treatment. CASE PRESENTATION: In this case of a 36 year old woman, the elevated hCG level at presentation was helpful in making a clinical diagnosis of OGCT in a patient too unwell to permit a tissue diagnosis. Cisplatin based combination chemotherapy produced an initial normalisation of the hCG level, but later in treatment the patient developed new cerebral lesions and a rising serum hCG suggestive of disease progression. Further investigations suggested that the CNS lesions were cerebral TB and that the low levels of hCG elevations was likely to be pituitary in origin. Chemotherapy treatment was continued along with anti-tuberculous therapy and 24 months after successful completion of therapy the patient remains disease free. CONCLUSIONS: In the treatment of cancer patients it may be helpful to consider the potential non-malignant causes of new CNS lesions and that low hCG elevations may result from physiology rather than pathology in selected cases. BioMed Central 2010-06-29 /pmc/articles/PMC2909206/ /pubmed/20587067 http://dx.doi.org/10.1186/1471-2407-10-338 Text en Copyright ©2010 Rakha et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Rakha, Serena Bayliss, Clare Sanderson, Frances Smith, Richard Seckl, Michael Savage, Philip Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour |
title | Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour |
title_full | Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour |
title_fullStr | Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour |
title_full_unstemmed | Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour |
title_short | Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour |
title_sort | pituitary hcg production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909206/ https://www.ncbi.nlm.nih.gov/pubmed/20587067 http://dx.doi.org/10.1186/1471-2407-10-338 |
work_keys_str_mv | AT rakhaserena pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour AT baylissclare pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour AT sandersonfrances pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour AT smithrichard pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour AT secklmichael pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour AT savagephilip pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour |